META-ANALYSIS OF THE PARKINSON’S DISEASE ASSOCIATED ALTERATIONS IN GUT MICROBIOME AND METABOLOME PROFILE IDENTIFIES DISEASE-SPECIFIC BIOMARKERS FOR DIAGNOSTIC APPLICATION

Bibliographic Details
Main Authors:	P A Aneesa, Dania Jose, Syam Krishnan, P S Baby Chakrapani
Format:	Article
Language:	English
Published:	Elsevier 2023-10-01
Series:	IBRO Neuroscience Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667242123009740

Similar Items

Gut Microbiota and Metabolome Alterations Associated with Parkinson’s Disease
by: Sarah Vascellari, et al.
Published: (2020-10-01)

Altered Gut Microbiome and Intestinal Pathology in Parkinson’s Disease
by: Han-Lin Chiang, et al.
Published: (2019-05-01)

The potential of the gut microbiome for identifying Alzheimer’s disease diagnostic biomarkers and future therapies
by: Yu Zhan, et al.
Published: (2023-04-01)

Gut microbiome and serum metabolome analyses identify molecular biomarkers and altered glutamate metabolism in fibromyalgiaResearch in context
by: Marc Clos-Garcia, et al.
Published: (2019-08-01)

The Role of an Altered Gut Microbiome in Parkinson’s Disease: A Narrative Review
by: Sara Hashish, et al.
Published: (2023-05-01)

Gut microbiome, metabolome, and allergic diseases
by: So-ichiro Hirata, et al.
Published: (2017-10-01)

Disease‐associated gut microbiome and critical metabolomic alterations in patients with colorectal cancer
by: Hongze Zhang, et al.
Published: (2023-07-01)

Diet and the gut microbiome in patients with Parkinson’s disease
by: Dayoon Kwon, et al.
Published: (2024-04-01)

Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions
by: Federico Baldini, et al.
Published: (2020-06-01)

Unlocking the Potential of the Human Microbiome for Identifying Disease Diagnostic Biomarkers
by: Rima Hajjo, et al.
Published: (2022-07-01)

Gut microbiome and serum metabolome analyses identify biomarkers associated with sexual maturity in quails
by: Xinwei Xiong, et al.
Published: (2023-07-01)

Gut microbiome and plasma metabolome alterations in myopic mice
by: Hao Li, et al.
Published: (2023-12-01)

Meta-analysis of the Parkinson’s disease gut microbiome suggests alterations linked to intestinal inflammation
by: Stefano Romano, et al.
Published: (2021-03-01)

Parkinson’s disease alters the composition of subgingival microbiome
by: Ekin Yay, et al.
Published: (2023-12-01)

Metabolomics tools for identifying biomarkers for neuropsychiatric diseases
by: Marlon P. Quinones, et al.
Published: (2009-08-01)

Potential for Novel Biomarkers in Diabetes-Associated Chronic Kidney Disease: Epigenome, Metabolome, and Gut Microbiome
by: Ashani Lecamwasam, et al.
Published: (2020-09-01)

Diagnostic metabolomic profiling of Parkinson's disease biospecimens
by: Peter A. LeWitt, et al.
Published: (2023-02-01)

Gut Microbiome and Serum Metabolome Alterations Associated with Isolated Dystonia
by: Lingyan Ma, et al.
Published: (2021-08-01)

Exploring human-genome gut-microbiome interaction in Parkinson’s disease
by: Zachary D. Wallen, et al.
Published: (2021-08-01)

Gut microbiome alterations in preclinical Alzheimer's disease.
by: Joon Hyung Jung, et al.
Published: (2022-01-01)

Gut microbiome alterations in preclinical Alzheimer’s disease
by: Joon Hyung Jung, et al.
Published: (2022-01-01)

The Microbiome-Gut-Brain Axis, Nutrition and Parkinson’s Disease
by: Jevgenija Guk, et al.
Published: (2024-03-01)

The gut microbiome as a factor in the development of Parkinson's disease
by: L. A. Brsikyan, et al.
Published: (2023-02-01)

Study of the gut microbiome in Egyptian patients with Parkinson’s Disease
by: Mohammad Mehanna, et al.
Published: (2023-07-01)

Gut microbiome and Parkinson's disease: Perspective on pathogenesis and treatment
by: Safa Salim, et al.
Published: (2023-08-01)

Diagnostic potential of gut microbiota in Parkinson’s disease
by: V. A. Petrov, et al.
Published: (2020-01-01)

Machine learning strategy for identifying altered gut microbiomes for diagnostic screening in myasthenia gravis
by: Che-Cheng Chang, et al.
Published: (2023-09-01)

The Role of the Canine Gut Microbiome and Metabolome in Health and Gastrointestinal Disease
by: Rachel Pilla, et al.
Published: (2020-01-01)

Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms
by: Zachary D. Wallen, et al.
Published: (2022-11-01)

Smelling Parkinson’s Disease: New Metabolomic Biomarker for PD
by: Werner Poewe
Published: (2019-04-01)

Alterations in the gut microbiome and metabolome profiles of septic rats treated with aminophylline
by: Yuanzhe Li, et al.
Published: (2022-02-01)

Correction: Study of the gut microbiome in Egyptian patients with Parkinson’s Disease
by: Mohammad Mehanna, et al.
Published: (2024-07-01)

Gut microbiome is not associated with mild cognitive impairment in Parkinson’s disease
by: Velma T. E. Aho, et al.
Published: (2024-04-01)

Therapies for Parkinson’s disease and the gut microbiome: evidence for bidirectional connection
by: Grace Hey, et al.
Published: (2023-05-01)

Nutritional Intake and Gut Microbiome Composition Predict Parkinson’s Disease
by: Michal Lubomski, et al.
Published: (2022-05-01)

Alterations of the Human Gut Microbiome in Chronic Kidney Disease
by: Zhigang Ren, et al.
Published: (2020-10-01)

Altered Gut Microbiome in Parkinson’s Disease and the Influence of Lipopolysaccharide in a Human α-Synuclein Over-Expressing Mouse Model
by: Anastazja M. Gorecki, et al.
Published: (2019-08-01)

Microbiome–metabolome reveals the contribution of gut–kidney axis on kidney disease
by: Yuan-Yuan Chen, et al.
Published: (2019-01-01)

Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease
by: Kate L. Bowerman, et al.
Published: (2020-11-01)

Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response
by: Yue Shen, et al.
Published: (2023-12-01)